Contract Manufacturing

Lonza in deal to manufacture Cellectis’ UCART oncology pipeline

03-Oct-2019 By Vassia Barba

Cellectis chooses Lonza to take on the clinical manufacturing of its UCART blood cancer immunotherapy candidates, intended to be marketed as industrialized, readily available CAR-T cells.

Almac joins clinical supply blockchain working group

24-Sep-2019 By Vassia Barba

Almac joins a working group made up of clinical supply chain industry members, in order to contribute to the use case discussion about blockchain technology.

Early manufacturing life-saving for biologics developers, says CMO exec

23-Sep-2019 By Vassia Barba

‘Talk to your CDMO early’ is the advice BioConnection gives to developers of biopharmaceuticals, suggesting that they make a reservation to ensure availability.

Vineti, Cryoport partner to extend end-to-end cell therapy logistics offering

10-Sep-2019 By Vassia Barba

A collaboration between Vineti and Cryoport aims to extend supply chain services as the cell and gene therapies space continues to scale.

Catalent adds to its clinical supply business with new facility

09-Sep-2019 By Vassia Barba

Catalent to invest $9m in the building of an early-stage clinical supply facility in San Diego, due to open in the summer of 2020, to integrate its CDMO business.

Velesco acquires facility, triples clinical manufacturing capacity

05-Sep-2019 By Vassia Barba

Velesco to triple its capacity for non-sterile clinical material manufacturing and consolidate its cGMP capabilities with the purchase of a facility in Wixom, Michigan.

People on the Move: Outsourcing-Pharma roundup August ‘19

04-Sep-2019 By Melissa Fassbender

The last month of summer saw several hires, including a lead for Worldwide Clinical Trials’ Japan operations, CEO appointments at CordenPharma and LabConnect, and Altasciences’ new CSO, who joins the company from Syneos.

Orgenesis reports record revenue as it looks to develop scalable processing solutions for cell therapies

03-Sep-2019 By Melissa Fassbender

Orgenesis is developing a ‘distributed’ processing solution – backed by its point-of-care cell therapy platform and CDMO business – to provide approved cell therapies to patients at a fraction of today’s costs, says company executive.

Lonza and Chr. Hansen kickstart BacThera JV with €90m

02-Sep-2019 By Vassia Barba

Chr. Hansen and Lonza name their joint venture CDMO for live biotherapeutics and ready the launch after receiving antitrust approvals.

Chinese CDMO contracted to manufacture Pfizer’s oncology candidate

27-Aug-2019 By Vassia Barba

CMAB Biopharma to support Kintor in the clinical development of a potential treatment for liver cancer, ahead of regulatory filing.

Cellular therapy CDMO Cognate closes growth capital round

27-Aug-2019 By Maggie Lynch

Cognate BioServices closes a round of growth capital from EW Healthcare Partners to secure its capabilities for the commercialization of advanced cellular therapies.

Cancer Research UK backs Hummingbird’s cancer treatment development

13-Aug-2019 By Vassia Barba

Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.

The complete package: Sartorius Stedim adds cell bank manufacture

12-Aug-2019 By Maggie Lynch

Sartorius Stedim to offer the GMP manufacture of mammalian cell banks for the biopharmaceutical industry alongside characterization services.

Permira Funds acquires Cambrex in $2.4bn deal

08-Aug-2019 By Vassia Barba

Cambrex is acquired by an affiliate of Permira Funds for $2.4bn, and will continue investing ‘aggressively’ to support its global customer base.

People on the Move: Outsourcing-Pharma roundup July ‘19

02-Aug-2019 By Melissa Fassbender

CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.